A Bayesian Method for Detecting and Characterizing Allelic Heterogeneity and Boosting Signals in Genome-Wide Association Studies

被引:15
|
作者
Su, Zhan [1 ,2 ]
Cardin, Niall [1 ]
Donnelly, Peter [1 ,2 ]
Marchini, Jonathan [1 ,2 ]
机构
[1] Univ Oxford, Dept Stat, Oxford OX1 3TG, England
[2] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England
基金
英国惠康基金; 英国工程与自然科学研究理事会;
关键词
Complex disease; genome-wide association; allelic heterogeneity; Bayesian methods; SUSCEPTIBILITY LOCI; LINKAGE DISEQUILIBRIUM; CROHN-DISEASE; VARIANTS; REPLICATION; IMPUTATION; GENES;
D O I
10.1214/09-STS311
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
The standard paradigm for the analysis of genome-wide association studies involves carrying out association tests at both typed and imputed SNPs. These methods will not be optimal for detecting the signal of association at SNPs that are not currently known or in regions where allelic heterogeneity occurs. We propose a novel association test, complementary to the SNP-based approaches, that attempts to extract further signals of association by explicitly modeling and estimating both unknown SNPs and allelic heterogeneity at a locus. At each site we estimate the genealogy of the case-control sample by taking advantage of the HapMap haplotypes across the genome. Allelic heterogeneity is modeled by allowing more than one mutation on the branches of the genealogy. Our use of Bayesian methods allows us to assess directly the evidence for a causative SNP not well correlated with known SNPs and for allelic heterogeneity at each locus. Using simulated data and real data from the WTCCC project, we show that our method (i) produces a significant boost in signal and accurately identifies the form of the allelic heterogeneity in regions where it is known to exist, (ii) can suggest new signals that are not found by testing typed or imputed SNPs and (iii) can provide more accurate estimates of effect sizes in regions of association.
引用
收藏
页码:430 / 450
页数:21
相关论文
共 50 条
  • [1] Detecting signals in pharmacogenomic genome-wide association studies
    J Wakefield
    V Skrivankova
    F-C Hsu
    M Sale
    P Heagerty
    The Pharmacogenomics Journal, 2014, 14 : 309 - 315
  • [2] Detecting signals in pharmacogenomic genome-wide association studies
    Wakefield, J.
    Skrivankova, V.
    Hsu, F-C
    Sale, M.
    Heagerty, P.
    PHARMACOGENOMICS JOURNAL, 2014, 14 (04): : 309 - 315
  • [3] bNEAT: a Bayesian network method for detecting epistatic interactions in genome-wide association studies
    Bing Han
    Xue-wen Chen
    BMC Genomics, 12
  • [4] bNEAT: a Bayesian network method for detecting epistatic interactions in genome-wide association studies
    Han, Bing
    Chen, Xue-wen
    BMC GENOMICS, 2011, 12
  • [5] GENOME-WIDE ASSOCIATION STUDIES Validating, augmenting and refining genome-wide association signals
    Ioannidis, John P. A.
    Thomas, Gilles
    Daly, Mark J.
    NATURE REVIEWS GENETICS, 2009, 10 (05) : 318 - 329
  • [6] The Bayesian lasso for genome-wide association studies
    Li, Jiahan
    Das, Kiranmoy
    Fu, Guifang
    Li, Runze
    Wu, Rongling
    BIOINFORMATICS, 2011, 27 (04) : 516 - 523
  • [7] ALLELIC EXPRESSION IMBALANCE REFINED GENOME-WIDE ASSOCIATION SIGNALS IN OSTEOARTHRITIS
    de Almeida, R. C.
    Den Hollander, W.
    Nelissen, R. R.
    Mei, L.
    Meulenbelt, I.
    OSTEOARTHRITIS AND CARTILAGE, 2021, 29 : S313 - S313
  • [8] Genome-wide association studies for detecting cancer susceptibility
    Hosking, Fay J.
    Dobbins, Sara E.
    Houlston, Richard S.
    BRITISH MEDICAL BULLETIN, 2011, 97 (01) : 27 - 46
  • [9] Bayesian Variable Selection with Genome-wide Association Studies
    Bangchang, Kannat Na
    LOBACHEVSKII JOURNAL OF MATHEMATICS, 2024, 45 (02) : 613 - 620
  • [10] Bayesian Centroid Inference for Genome-Wide Association Studies
    Carvalho, Luis E.
    GENETIC EPIDEMIOLOGY, 2010, 34 (08) : 981 - 982